from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2578c/-

LFCtreatmentdescriptionclass of inhibitor

-0.657

Amikacinug/mL Amikacintranslation

-0.492

Cap5-10ug/mL Capreomycintranslation

-0.566

Rox10-50 ug/mL Roxithromycintranslation

-0.017

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.441

Rif0.2-5ug/mL Rifampicintranscription

-0.345

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.246

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.379

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.355

CPZ10-50 ug/mL Chlorpromazinerespiration

0.902

Clofazimine10-13 ug/mL Clofaziminerespiration

0.031

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.278

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.818

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.122

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.746

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.551

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.003

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.869

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.205

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.487

KCN5-20 ug/mL Potassium cyaniderespiration

-1.160

NaN30.2-2 mM Sodium aziderespiration

-0.666

Nigericin50 uM Nigericinrespiration

0.164

TRC10-150 ug/mL Triclosanrespiration

-0.650

TRZ10-25 ug/mL Thioridazinerespiration

-0.256

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.451

menadione6-10 ug/mL Menadionerespiration

-0.475

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.228

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.037

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.085

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.922

NRP_1Non-replicating persistence stage 1dosRassociated

-0.469

Amp0.2mg/mL AmpicillincellWall

-0.462

Cephalexin20-100 ug/mL CephalexincellWall

0.107

Cerulenin0.32-5 ug/mL CerulenincellWall

0.101

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.363

EMB10-20 ug/mL EthambutolcellWall

0.204

Eta12-40 ug/mL EthionamidecellWall

-0.331

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.074

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.099

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.130

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.334

BZA0.12 mg/mL BenzamidearomaticAmides

-0.293

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.073

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.011

H2O24 mM hydrogen peroxideDNAdamaging

0.092

Levo10 ug/mL LevofloxacinDNAdamaging

0.695

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.645

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.414

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.777

UVUV-irradiationDNAdamaging

-0.430

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.645

Antimycin12.5-50 ug/mL Antimycin A?

-0.301

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.086

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.329

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.750

PA8240.2-2 ug/mL PA-824?

1.169

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.486

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.199

Verapamil50 uM Verapamil?

0.015

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.037

methoxatin10-20 ug/mL Methoxatin?